Biologic for Rare Form of Psoriasis Under FDA Priority Review

The Food and Drug Administration has accepted a Biologics License Application for spesolimab, a selective antibody that blocks interleukin-36 receptors, for the treatment of flares in patients with generalized pustular psoriasis, according to a statement from manufacturer Boehringer Ingelheim. The FDA also granted Priority Review to spesolimab. Priority Review is a designation granted to medications that would offer significant improvement over the currently available treatments.

Generalized pustular psoriasis (GPP), though rare, is a potentially life-threatening condition that is distinct from plaque psoriasis. Throughout the course of the disease, which is caused by the accumulation of neutrophils in the skin, patients may experience persistent disease with intermittent flares or relapsing disease with recurrent flares. The neutrophil accumulation results in the eruption of sterile, yet painful pustules across all parts of the body.

“While the severity of GPP flares can vary, if left untreated they can be life threatening due to complications such as sepsis and multisystem organ failure,” and have a significant impact on quality of life, according to the company statement.

The FDA also has granted spesolimab an Orphan Drug Designation for the treatment of GPP, and a Breakthrough Therapy Designation for the treatment of GPP flares in adults.

A marketing authorization application for spesolimab for the treatment of GPP was accepted for evaluation by the European Medicines Agency in October 2021, according to a company press release issued at that time.

A protocol for a phase 2 study of spesolimab versus placebo for treating acute flares in GPP patients was published in October in BMJ Open, after a phase 1 proof-of-concept study published in 2019 showed the potential of an IL-36 receptor antagonist to improve disease scores in adults with GPP.

More information is available on the Boehringer Ingelheim website.

This article originally appeared on MDedge.com, part of the Medscape Professional Network.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Hand strikes head... 6-year-old boy who was beaten for a long time, the director also attempted to conceal the incident [Video] thumbnail

Hand strikes head… 6-year-old boy who was beaten for a long time, the director also attempted to conceal the incident [Video]

6세 아동에 위협·폭행한 어린이집 보육교사 CCTV 영상. YTN 보도화면 캡처 6세 아동에 위협·폭행한 어린이집 보육교사 CCTV 영상. YTN 보도화면 캡처 경북 포항의 한 어린이집 보육교사가 6세 남아를 장기간 폭행한 사건이 알려져 공분을 사고 있다. 아이는 심리치료 20회가 필요하다는 진단을 받고, 현재 아동심리치료센터를 방문해 치료를 받고 있는 것으로 알려졌다. 25일 YTN은 보도를 통해 피해 아동이 지난 6월부터 목과 팔에 상처를…
Read More
Beverly Hills 90210 star Jennie Garth's daughter turns 18 thumbnail

Beverly Hills 90210 star Jennie Garth’s daughter turns 18

Los Angeles correspondentLos AngelesOctober 5, 2024Oct 5, 2024, 9:10 PM GMT+1 Jennie Garth and Twilight star Peter Facinelli's youngest daughter turned 18 this week and the teen is the spitting image of her mom during her Beverly Hills 90210 days.© Instagram"My baby girl, you are so strong, intelligent and brave, I watch you growing into this
Read More
Mental Health Crisis Teams Aren’t Just for Cities Anymore thumbnail

Mental Health Crisis Teams Aren’t Just for Cities Anymore

NEWTON, Iowa — Jeff White knows what can happen when 911 dispatchers receive a call about someone who feels despondent or agitated. He experienced it repeatedly: The 911 operators dispatched police, who often took him to a hospital or jail. “They don’t know how to handle people like me,” said White, who struggles with depression
Read More
Index Of News
Total
0
Share